2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Microbix Presenting Product Results to Industry
Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™MISSISSAUGA, Ontario, July 08, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems...
Global WholeHealth Partners Corp (OTC:GWHP) Ships Its First Shipment of Over 20,000 Tests to Salud Previa of Tijuana, MX; Salud Previa Has Indicated That It Plans on Purchasing More Than 500,000 Tests Over the Next 12 Months
San Clemente, CA, July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of...
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
WAYNE, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in...
AGTC to Host Virtual R&D Day on July 22, 2021
Widely Recognized Experts and AGTC Leadership Will Expand on Recent ACHM Phase 1/2 Clinical Trial Data and Discuss XLRP Milestones...
Evaxion Biotech Reports Data from Phase 1/2a Trials of EVX-01 and EVX-02
New clinical data demonstrates antitumor effect of EVX-01 in combination with anti-PD1 treatmentObjective Response Rate (ORR) of 67% with EVX-01...
Dante Labs commits to ending Rare Disease Odysseys globally through Stripe2be: a patient-centric whole genome based solution tailored for rare disease patients
Dante Labs Clinical Laboratory A DNA and RNA extraction room in Dante Labs Clinical Laboratory Stripe2be uses an unbiased approach...
Active Biotech’s partner NeoTX will host KOL webinar on overcoming check point Inhibitor resistance
Lund, July 8 2021 - Active Biotech (Nasdaq Stockholm: ACTI) today provided information that its partner in the naptumomab project,...
Chr. Hansen Holding A/S Interim Report Q3 2020/21
July 8, 2021 Company announcement no. 9 Third quarter in line with expectations and outlook for 2020/21 unchanged Q3 2020/21...
32,884 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE 8 JULY 2021 at 9.00 EEST 32,884 Orion Corporation A shares converted into B...
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in...
Biophytis Reinforces Leadership Teams with Three Senior Appointments
Claude Allary to be member of Board of Directors Benoit Canolle is appointed Chief Business OfficerJean Mariani, Chairman of Biophytis...
Hyloris Announces Launch of Maxigesic® IV, a Novel Non-Opioid Pain Treatment, in Key European Markets
Marks first European launches of Maxigesic IV, a well-tolerated and effective non-opioid pain treatment Liège, Belgium...
Disclosure of received notification of Mawer Investment Management
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 July 2021 Disclosure of received notification of Mawer Investment Management Pursuant to the Belgian...
Top Adrenal Cancer and Tumor Surgeon Dr Carling Opens Surgery Center in Tampa FL
The Norman/Clayman Endocrine Institute announced that Dr Carling departed his position at Yale University to open the Carling Adrenal Center...
Therma Bright’s AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Successfully Detects the COVID-19 Delta Variant Strain
Toronto, Ontario--(Newsfile Corp. - July 8, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its...
Fist Assist Devices, LLC Announces U.S. Distribution Deal and Sales Launch
AIROS Medical, Inc. Selected for Commercialization Affiliate for July Launch LOS ALTOS HILLS, Calif.--(BUSINESS WIRE)--Fist Assist Devices, LLC, announces a...
Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp.
The transaction will combine Hyperfine, creator of the innovative Portable MR Imaging System, Swoop™, with Liminal Sciences, a medical technology...
Axonics® to Report Second Quarter 2021 Financial Results on August 5, 2021
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
AiCuris Starts Its First Pivotal Clinical Phase 3 Trial with Pritelivir for the Treatment of HSV Infections in Immunocompromised Subjects Based on Efficacy and Safety Data from a Phase 2 Trial
The development program focuses on the treatment of immunocompromised patients whose herpes simplex virus (HSV) infections have become resistant to...